Found: 44
Select item for more details and to access through your institution.
Adjuvant Trastuzumab Therapy: Can We Balance Efficacy and Safety?
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. 1405, doi. 10.1634/theoncologist.2019-0263
- By:
- Publication type:
- Article
Safe Opioid Use, Storage, and Disposal Strategies in Cancer Pain Management.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. 1410, doi. 10.1634/theoncologist.2019-0242
- By:
- Publication type:
- Article
Dual Checkpoint Inhibition with Ipilimumab plus Nivolumab After Progression on Sequential PD‐1/PDL‐1 Inhibitors Pembrolizumab and Atezolizumab in a Patient with Lynch Syndrome, Metastatic Colon, and Localized Urothelial Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. 1416, doi. 10.1634/theoncologist.2018-0686
- By:
- Publication type:
- Article
Randomized Phase II Study of Weekly Paclitaxel plus Carboplatin Versus Biweekly Paclitaxel plus Carboplatin for Patients with Previously Untreated Advanced Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. 1420, doi. 10.1634/theoncologist.2019-0513
- By:
- Publication type:
- Article
Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. 1422, doi. 10.1634/theoncologist.2019-0497
- By:
- Publication type:
- Article
Impact of 21‐Gene Breast Cancer Assay on Treatment Decision for Patients with T1–T3, N0–N1, Estrogen Receptor‐Positive/Human Epidermal Growth Receptor 2‐Negative Breast Cancer: Final Results of the Prospective Multicenter ROXANE Study
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. 1424, doi. 10.1634/theoncologist.2019-0103
- By:
- Publication type:
- Article
Fracture Risk in Women with Breast Cancer Initiating Aromatase Inhibitor Therapy: A Registry‐Based Cohort Study.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. 1432, doi. 10.1634/theoncologist.2019-0149
- By:
- Publication type:
- Article
A Phase Ib Trial of Durvalumab in Combination with Trastuzumab in HER2‐Positive Metastatic Breast Cancer (CCTG IND.229).
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. 1439, doi. 10.1634/theoncologist.2019-0321
- By:
- Publication type:
- Article
TELEPRO: Patient‐Reported Carcinoid Syndrome Symptom Improvement Following Initiation of Telotristat Ethyl in the Real World.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. 1446, doi. 10.1634/theoncologist.2018-0921
- By:
- Publication type:
- Article
Safety of Nivolumab plus Low‐Dose Ipilimumab in Previously Treated Microsatellite Instability‐High/Mismatch Repair‐Deficient Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. 1453, doi. 10.1634/theoncologist.2019-0129
- By:
- Publication type:
- Article
FGFR2‐Altered Gastroesophageal Adenocarcinomas Are an Uncommon Clinicopathologic Entity with a Distinct Genomic Landscape.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. 1462, doi. 10.1634/theoncologist.2019-0121
- By:
- Publication type:
- Article
Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. 1469, doi. 10.1634/theoncologist.2019-0175
- By:
- Publication type:
- Article
Patient‐Reported Factors in Treatment Satisfaction in Patients with Relapsed/Refractory Multiple Myeloma (RRMM).
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. 1479, doi. 10.1634/theoncologist.2018-0724
- By:
- Publication type:
- Article
Contemporary Outcomes for Advanced‐Stage Classical Hodgkin Lymphoma in the U.S.: Analysis of Surveillance, Epidemiology, and End Results Database.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. 1488, doi. 10.1634/theoncologist.2019-0172
- By:
- Publication type:
- Article
Empiric Therapy with BRAF and MEK Inhibitors in Metastatic Melanoma.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. 1495, doi. 10.1634/theoncologist.2019-0332
- By:
- Publication type:
- Article
Cabozantinib Versus Sunitinib for Untreated Patients with Advanced Renal Cell Carcinoma of Intermediate or Poor Risk: Subgroup Analysis of the Alliance A031203 CABOSUN trial.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. 1497, doi. 10.1634/theoncologist.2019-0316
- By:
- Publication type:
- Article
Miles and Memories.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. 1502, doi. 10.1634/theoncologist.2019-0586
- By:
- Publication type:
- Article
Evaluation of the Incorporation of Recurrence Score into the American Joint Committee on Cancer Eighth Edition Staging System in Patients with T1‐2N0M0, Estrogen Receptor‐Positive, Human Epidermal Growth Receptor 2‐Negative Invasive Breast Cancer: A Population‐Based Analysis
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1014, doi. 10.1634/theoncologist.2018-0727
- By:
- Publication type:
- Article
A Pilot, Phase II, Randomized, Open‐Label Clinical Trial Comparing the Neurotoxicity of Three Dose Regimens of Nab‐Paclitaxel to That of Solvent‐Based Paclitaxel as the First‐Line Treatment for Patients with Human Epidermal Growth Factor Receptor Type 2‐Negative Metastatic Breast Cancer
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1024, doi. 10.1634/theoncologist.2017-0664
- By:
- Publication type:
- Article
Prevention, Monitoring, and Management of Cardiac Dysfunction in Patients with Metastatic Breast Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1034, doi. 10.1634/theoncologist.2018-0773
- By:
- Publication type:
- Article
Incorporating MicroRNA into Molecular Phenotypes of Circulating Tumor Cells Enhances the Prognostic Accuracy for Patients with Metastatic Breast Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1044, doi. 10.1634/theoncologist.2018-0697
- By:
- Publication type:
- Article
Programmed Cell Death Ligand 1 in Breast Cancer: Technical Aspects, Prognostic Implications, and Predictive Value.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1055, doi. 10.1634/theoncologist.2019-0197
- By:
- Publication type:
- Article
Genomic Signature of Driver Genes Identified by Target Next‐Generation Sequencing in Chinese Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1070, doi. 10.1634/theoncologist.2018-0572
- By:
- Publication type:
- Article
Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients' Outcome in Neuroendocrine Tumors (NET)—The GREPONET Study.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1082, doi. 10.1634/theoncologist.2018-0672
- By:
- Publication type:
- Article
Prognostic Value and Association of Sarcopenia and Systemic Inflammation for Patients with Gastric Cancer Following Radical Gastrectomy.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1091, doi. 10.1634/theoncologist.2018-0651
- By:
- Publication type:
- Article
Accuracy and Prognostic Significance of Oncologists' Estimates and Scenarios for Survival Time in Advanced Gastric Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1102, doi. 10.1634/theoncologist.2018-0613
- By:
- Publication type:
- Article
Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1108, doi. 10.1634/theoncologist.2018-0896
- By:
- Publication type:
- Article
Prospective Biomarker Study in Advanced RAS Wild‐Type Colorectal Cancer: POSIBA Trial (GEMCAD 10‐02).
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1115, doi. 10.1634/theoncologist.2018-0728
- By:
- Publication type:
- Article
Complete Blood Count Score Model Integrating Reduced Lymphocyte‐Monocyte Ratio, Elevated Neutrophil‐Lymphocyte Ratio, and Elevated Platelet‐Lymphocyte Ratio Predicts Inferior Clinical Outcomes in Adult T‐Lymphoblastic Lymphoma.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1123, doi. 10.1634/theoncologist.2018-0789
- By:
- Publication type:
- Article
1q21 Gain Combined with High‐Risk Factors Is a Heterogeneous Prognostic Factor in Newly Diagnosed Multiple Myeloma: A Multicenter Study in China.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1132, doi. 10.1634/theoncologist.2019-0132
- By:
- Publication type:
- Article
Planned Pregnancy in Female Patients with Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitor Therapy.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1141, doi. 10.1634/theoncologist.2019-0109
- By:
- Publication type:
- Article
Sex Differences in Tolerability to Anti‐Programmed Cell Death Protein 1 Therapy in Patients with Metastatic Melanoma and Non‐Small Cell Lung Cancer: Are We All Equal?
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1148, doi. 10.1634/theoncologist.2019-0094
- By:
- Publication type:
- Article
Computed Tomography‐Based Radiomics Signature: A Potential Indicator of Epidermal Growth Factor Receptor Mutation in Pulmonary Adenocarcinoma Appearing as a Subsolid Nodule.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1156, doi. 10.1634/theoncologist.2018-0706
- By:
- Publication type:
- Article
Italian Cohort of Nivolumab Expanded Access Program in Squamous Non‐Small Cell Lung Cancer: Results from a Real‐World Population.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1165, doi. 10.1634/theoncologist.2018-0737
- By:
- Publication type:
- Article
Analysis of DLL3 and ASCL1 in Surgically Resected Small Cell Lung Cancer (HOT1702).
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1172, doi. 10.1634/theoncologist.2018-0676
- By:
- Publication type:
- Article
A Multicenter Comparison of Complementary and Alternative Medicine (CAM) Discussions in Oncology Care: The Role of Time, Patient‐Centeredness, and Practice Context.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1180, doi. 10.1634/theoncologist.2019-0093
- By:
- Publication type:
- Article
Balancing the Hype with Reality: What Do Patients with Advanced Melanoma Consider When Making the Decision to Have Immunotherapy?
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1190, doi. 10.1634/theoncologist.2018-0820
- By:
- Publication type:
- Article
Comprehensive Clinical Trial Data Summation for BRAF‐MEK Inhibition and Checkpoint Immunotherapy in Metastatic Melanoma.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1197, doi. 10.1634/theoncologist.2018-0876
- By:
- Publication type:
- Article
Phase II Trial of Continuous Regorafenib Dosing in Patients with Gastrointestinal Stromal Tumors After Failure of Imatinib and Sunitinib.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1212, doi. 10.1634/theoncologist.2019-0033
- By:
- Publication type:
- Article
Acceptability of Routine Evaluations Using Patient‐Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient‐Reported Symptom Outcome Tools in Cancer Outpatients: Princess Margaret Cancer Centre Experience.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1219, doi. 10.1634/theoncologist.2018-0830
- By:
- Publication type:
- Article
Serious Cutaneous Toxicities with Immune Checkpoint Inhibitors in the U.S. Food and Drug Administration Adverse Event Reporting System.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1228, doi. 10.1634/theoncologist.2019-0250
- By:
- Publication type:
- Article
Pediatric NUT Carcinoma Is a Rare and Challenging Tumor: Single Center Experience of Five Children.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1232, doi. 10.1634/theoncologist.2019-0358
- By:
- Publication type:
- Article
Follicular Lymphoma: Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet Needs.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1236, doi. 10.1634/theoncologist.2019-0138
- By:
- Publication type:
- Article
Prognostic Nomogram for Overall Survival in Patients with Diffuse Large B‐Cell Lymphoma.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1251, doi. 10.1634/theoncologist.2018-0361
- By:
- Publication type:
- Article